Vol. 44 No. 3 (2005): Acta Oncologica

Adenovirus-mediated human topoisomerase IIα gene transfer increases the sensitivity of etoposide-resistant human and mouse breast cancer cells

• PDF

High-dose radiotherapy and concurrent UFT plus l-leucovorin in locally advanced rectal cancer: A phase I trial

• PDF

Is screening for prostate cancer with prostate specific antigen an appropriate public health measure?

• PDF

Alteration of gonadotropin-releasing hormone receptor expression with the progression of prostate cancer in the Dunning rat adenocarcinoma sublines

• PDF

Targeted drugs in metastatic colorectal cancer with special emphasis on guidelines for the use of bevacizumab and cetuximab: An Acta Oncologica expert report

Skeletal complications of prostate cancer: Pathophysiology and therapeutic potential of bisphosphonates

• PDF

Multicenter phase II study of oral capecitabine plus irinotecan as first-line chemotherapy in advanced colorectal cancer: A Korean Cancer Study Group Trial

• PDF

The radiobiology of prostate cancer including new aspects of fractionated radiotherapy

• PDF

Abstracts of Theses from the Nordic Countries

• PDF

Lifestyle and 30-day complications to surgery for colorectal cancer

• PDF

Primary systemic chemotherapy with sequential, dose-dense epirubicin and docetaxel for inoperable, locally advanced inflammatory breast cancer: A phase II study

• PDF

Thrombospondins, metallo proteases and thrombospondin receptors messenger RNA and protein expression in different tumour sublines of the Dunning prostate cancer model

• PDF

Expert opinions – consensus documents – systematic overviews – is the value for clinicians increasing?

• PDF

Capecitabine as third line therapy in patients with advanced colorectal cancer

• PDF

Diet, lifestyle and risk of prostate cancer

• PDF